via CDC
The worst Ebola virus disease outbreak in history ended in 2016 after infecting 28,600 people and killing about 11,300 worldwide.
The outbreak led to urgent action by medical experts across the world to combat this devastating disease; including the setting up of trials of vaccines to stop the disease taking hold.
This global commitment to develop a vaccine against the disease suggested eight options, out of a starting pool of 15 candidates, should be evaluated in clinical trials worldwide by the end of 2015.
Professor Sanjeev Krishna, of St George’s University of London’s Institute for Infection and Immunity, said: “An unprecedented Ebola outbreak showed how it is possible for academics, non-governmental organisations, industry and funders to work effectively together very quickly in times of medical crisis. The results of the trial show how a vaccine could best be used to tackle this terrible disease effectively.
“We need a system of specialists, medical experts and organisers that maintains vigilance against outbreak diseases like Ebola.
“We should continue to improve ways to make, evaluate and deliver vaccines when they are needed, often in parts of the world lacking in infrastructure for diagnosing infections and providing treatments.”
He explained that considering the persistent replication of the vaccine which is called rVSV-?GP-ZEBOV in children and adolescents, further studies investigating lower doses in this population are warranted.
The vaccine contains a non-infectious portion of a gene from the Zaire Ebola virus. The St George’s researchers worked with colleagues on a vaccine trial in Gabon.
In addition, lower vaccine doses should be considered when boosting individuals with pre-existing antibodies to Ebolavirus glycoprotein, a finding that has emerged after the vaccine was tested in a country that has experienced Ebolavirus outbreaks in the past.
The vaccine was one of two being examined as a ‘candidate’ option by the World Health Organisation to identify urgently a vaccine to combat the Ebola virus outbreak in West Africa.
The clinical trial was led by colleagues at University of Tübingen in Germany, coordinated by Professor Peter Kremsner with their partner institute CERMEL in Lambaréné, Gabon.
Learn more: Ebola vaccine tested in adults and children in Africa hailed a success
The Latest on: Ebola vaccine
- COVID-19: Moderna vaccine ‘effective against new variants’on January 25, 2021 at 9:23 am
Moderna said laboratory tests found that vaccination with its jab produced neutralising antibodies against all key emerging variants.
- What's in store for the next wave of vaccineson January 25, 2021 at 5:49 am
Hello,Happy Monday! We're starting off the day with some fresh vaccine news. First, Merck is discontinuing its COVID-19 vaccine trials, a major setback from the company that developed the only Ebola ...
- Supply chain delays affect planned stockpile of Ebola vaccineson January 19, 2021 at 5:02 pm
Supply chain delays must be addressed to speed up creation of a stockpile of vaccines against deadly Ebola disease, researchers say.
- Health and humanitarian organizations announce the establishment of a global Ebola vaccine stockpileon January 19, 2021 at 1:27 am
The International Coordinating Group (ICG) on Vaccine Provision, which includes the World Health Organization (WHO), UNICEF, the International Federation of Red Cross and Red Crescent Societies (IFRC) ...
- International health organizations establish global Ebola vaccine stockpileon January 18, 2021 at 8:42 pm
The four leading international health and humanitarian organizations announced today the establishment of a global Ebola vaccine stockpile to ensure outbreak response.
- Group readies 500,000 Ebola vaccine doseson January 13, 2021 at 8:14 am
A global emergency stockpile of 500,000 Ebola vaccine doses will be created to respond quickly to future outbreaks, the vaccine alliance Gavi said Tuesday. Low- and lower middle-income countries will ...
- Ebola vaccines stockpiled against future outbreakson January 12, 2021 at 12:06 pm
The World Health Organization and partners said Tuesday they are creating a global stockpile of Ebola vaccines to help stamp out future outbreaks. In a statement, WHO, Doctors Without ...
- UN bodies, partners set up Ebola vaccine stockpileon January 12, 2021 at 1:10 am
ANKARA Four international health and humanitarian groups have established a global Ebola vaccine stockpile in order to secure outbreak response, UNICEF ...
- WHO, others stockpile Ebola vaccineon January 12, 2021 at 12:33 am
The four leading international health and humanitarian organizations on Tuesday announced the establishment of a global Ebola vaccine stockpile to facilitate quick response to the outbreak of the ...
- UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile [EN/AR/RU]on January 11, 2021 at 4:01 pm
Arabic News and Press Release on World about Disaster Management, Health and Epidemic; published on 12 Jan 2021 by IFRC, MSF and 3 other organizations ...
via Google News and Bing News
